Exponent : to Announce Second Quarter of Fiscal Year 2021 Results and Host Quarterly Conference Call on July 29 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Exponent Welcomes Dr. John Doyle as Group Vice President for Health Sciences
May 17, 2021 09:00 ET | Source: Exponent, Inc. Exponent, Inc. Menlo Park, California, UNITED STATES
MENLO PARK, Calif., May 17, 2021 (GLOBE NEWSWIRE) Exponent, Inc. (NASDAQ: EXPO) today announced the hiring of John Doyle, Dr.P.H., as Group Vice President, Health Sciences.
Dr. Doyle will lead the firm’s Health Sciences team, which applies deep interdisciplinary expertise to evaluate a broad range of environmental, occupational, medical, and public health issues that face the world.
“I am incredibly excited to welcome John to the Exponent team. He brings unique experience and perspective to Exponent, having founded, built and led premium healthcare research consultancies focused on the international biopharmaceutical sector, and also having served as a pharmaceutical industry executive focused on innovation,” said Dr. Catherine Corrigan, Chief E
Operator
Good day, and welcome to the Exponent First Quarter and Fiscal Year 2021 Earnings Call. [Operator Instructions]
At this time, I would like to turn the conference over to Whitney Kukulka. Please go ahead, ma am.
Whitney Kukulka
Investor Relations
Thank you, operator. Good afternoon, ladies and gentlemen. Thank you for joining us on Exponent s first quarter of fiscal year 2021 financial results conference call. Please note that this call will be simultaneously webcast on the Investor Relations section of the Company s corporate website at www.exponent.com/investors. This conference call is the property of Exponent and any taping or other reproduction is expressly prohibited without prior written consent. Joining me on the call today are Dr. Catherine Corrigan, President and Chief Executive Officer; and Rich Schlenker, Executive Vice President and Chief Financial Officer.
Interview with the President and CEO: Exponent, Inc. (NASDAQ:EXPO)
Dr. Catherine Corrigan is the President and Chief Executive Officer of Exponent, Inc. Dr. Corrigan joined the Company in 1996, was promoted to Principal in the Biomechanics Practice in 2002, and to Corporate Vice President in 2005. In 2012, she was appointed Vice President of Exponent’s Transportation Group, overseeing the company’s Vehicle Engineering, Biomechanics, Human Factors, and Statistical and Data Sciences practices, as well as Visual Communications. She was appointed President of the company in 2016 and Chief Executive Officer in 2018. Dr. Corrigan has consulted in the area of injury biomechanics and on issues related to motor vehicle and product safety for more than 20 years. Dr. Corrigan holds a Ph.D. in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology, an M.S. in Mechanical Engineering from MIT, and a B.S.E. in Bioengineering from the University of Pennsylvania. Dr.
Exponent CEO Joins Prestigious National Academy of Engineering
Nachrichtenquelle: globenewswire | 12.02.2021, 00:08 | 117
Dr. Catherine Ford Corrigan elected for leadership in biomechanical engineering and scientific consulting MENLO PARK, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) On February 9, 2021, Catherine Ford Corrigan, Ph.D., joined the United States’ National Academy of Engineering (NAE), receiving one of the highest professional distinctions accorded to an engineer. Dr. Corrigan was recognized for her research on injury mechanics and mitigation as well as her leadership in biomechanical engineering and scientific consulting. Over the past 25 years, Dr. Corrigan has fostered a culture that attracts exceptional talent and accelerates the careers of hundreds of engineers, scientists, physicians, and